GENE ONLINE|News &
Opinion
Blog

Cystic Fibrosis
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
Why Cells Move Faster Through Mucus Than Blood
2022-07-28
First Successful Use of Phages for Treating Antibiotic-Resistant Lung Infection
2022-05-16
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
Ionis’ Inhaled Antisense Medicine Could Signal Decline for Cystic Fibrosis Medical Devices
2020-10-15
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
An Outlook on the Evolution of Cystic Fibrosis Care
2020-05-13
LATEST
2024 Nobel Prize in Medicine: Uncovering the Secrets of microRNA in Gene Regulation
2024-10-08
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
2024-10-07
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top